Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease.
Aouba A, Georgin-Lavialle S, Pagnoux C, Martin Silva N, Renand A, Galateau-Salle F, Le Toquin S, Bensadoun H, Larousserie F, Silvera S, Provost N, Candon S, Seror R, de Menthon M, Hermine O, Guillevin L, Bienvenu B. Aouba A, et al. Among authors: martin silva n. Blood. 2010 Nov 18;116(20):4070-6. doi: 10.1182/blood-2010-04-279240. Epub 2010 Aug 19. Blood. 2010. PMID: 20724540 Free article.
Neutrophilic Dermatoses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A French Multicenter Study of 17 Cases and Literature Review.
de Boysson H, Martin Silva N, de Moreuil C, Néel A, de Menthon M, Meyer O, Launay D, Pagnoux C, Guillevin L, Puéchal X, Bienvenu B, Aouba A; French Vasculitis Study Group, French Internal Medicine Society. de Boysson H, et al. Among authors: martin silva n. Medicine (Baltimore). 2016 Mar;95(11):e2957. doi: 10.1097/MD.0000000000002957. Medicine (Baltimore). 2016. PMID: 26986103 Free PMC article.
Superior efficacy and tolerance of reduced doses of vemurafenib plus anakinra in Erdheim-Chester disease: Towards the paradigm of combined targeting and immune therapies.
Franconieri F, Martin-Silva N, de Boysson H, Galateau-Salle F, Emile JF, Bienvenu B, Aouba A. Franconieri F, et al. Among authors: martin silva n. Acta Oncol. 2016 Jul;55(7):930-2. doi: 10.3109/0284186X.2015.1120885. Epub 2016 Mar 31. Acta Oncol. 2016. PMID: 27031008 No abstract available.
Giant Cell Arteritis-related Stroke: A Retrospective Multicenter Case-control Study.
de Boysson H, Liozon E, Larivière D, Samson M, Parienti JJ, Boutemy J, Maigné G, Martin Silva N, Ly K, Touzé E, Bonnotte B, Aouba A, Sacré K, Bienvenu B. de Boysson H, et al. Among authors: martin silva n. J Rheumatol. 2017 Mar;44(3):297-303. doi: 10.3899/jrheum.161033. Epub 2017 Jan 15. J Rheumatol. 2017. PMID: 28089985
Giant-cell arteritis: concordance study between aortic CT angiography and FDG-PET/CT in detection of large-vessel involvement.
de Boysson H, Dumont A, Liozon E, Lambert M, Boutemy J, Maigné G, Martin Silva N, Sultan A, Ly KH, Aide N, Manrique A, Bienvenu B, Aouba A. de Boysson H, et al. Among authors: martin silva n. Eur J Nucl Med Mol Imaging. 2017 Dec;44(13):2274-2279. doi: 10.1007/s00259-017-3774-5. Epub 2017 Jul 24. Eur J Nucl Med Mol Imaging. 2017. PMID: 28736805
Eculizumab reversed severe distal ischemic syndrome and glomerulonephritis with isolated C3 deposits associated with anti-factor H autoantibodies: a case report.
Deshayes S, Martin Silva N, Chatelet V, Chantepie S, Le Quintrec M, Comoz F, Bridoux F, Dragon-Durey MA, Aouba A. Deshayes S, et al. Among authors: martin silva n. Clin Rheumatol. 2018 Apr;37(4):1119-1122. doi: 10.1007/s10067-018-4058-6. Epub 2018 Mar 7. Clin Rheumatol. 2018. PMID: 29516279 Review.
65 results